Global Keytruda Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Keytruda Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
KEYTRUDA® (pembrolizumab) works as an immunotherapy to help fight certain cancers.
Keytruda report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Keytruda market is projected to reach US$ 46510 million in 2029, increasing from US$ 20940 million in 2022, with the CAGR of 10.5% during the period of 2024 to 2029. Demand from Retail Pharmacy and Hospital Pharmacy are the major drivers for the industry.
The Keytruda market is primarily driven by the growing demand for effective immunotherapy treatments for various types of cancer. Keytruda (pembrolizumab) is a checkpoint inhibitor that enhances the body's immune response against cancer cells, resulting in improved outcomes for patients. The increasing prevalence of cancer cases, coupled with the need for targeted therapies that offer fewer side effects compared to traditional treatments, contributes to market growth. Moreover, the expanding spectrum of approved indications for Keytruda, including advanced melanoma, lung cancer, and other malignancies, further propels adoption. However, challenges include the potential for immune-related adverse events and addressing the variability in patient responses to immunotherapy. Navigating the competitive landscape in the field of immunotherapies and the high costs associated with these treatments pose ongoing concerns. The market's success relies on continuous research to identify patient populations that can benefit from Keytruda, comprehensive patient education about potential side effects, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to optimize cancer treatment while addressing the evolving challenges associated with Keytruda therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Keytruda market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Segment by Type
100mg/Vail
50mg/Vail
Retail Pharmacy
Hospital Pharmacy
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Keytruda market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Keytruda, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Keytruda industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Keytruda in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Keytruda introduction, etc. Keytruda Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Keytruda market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Keytruda report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Keytruda market is projected to reach US$ 46510 million in 2029, increasing from US$ 20940 million in 2022, with the CAGR of 10.5% during the period of 2024 to 2029. Demand from Retail Pharmacy and Hospital Pharmacy are the major drivers for the industry.
The Keytruda market is primarily driven by the growing demand for effective immunotherapy treatments for various types of cancer. Keytruda (pembrolizumab) is a checkpoint inhibitor that enhances the body's immune response against cancer cells, resulting in improved outcomes for patients. The increasing prevalence of cancer cases, coupled with the need for targeted therapies that offer fewer side effects compared to traditional treatments, contributes to market growth. Moreover, the expanding spectrum of approved indications for Keytruda, including advanced melanoma, lung cancer, and other malignancies, further propels adoption. However, challenges include the potential for immune-related adverse events and addressing the variability in patient responses to immunotherapy. Navigating the competitive landscape in the field of immunotherapies and the high costs associated with these treatments pose ongoing concerns. The market's success relies on continuous research to identify patient populations that can benefit from Keytruda, comprehensive patient education about potential side effects, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to optimize cancer treatment while addressing the evolving challenges associated with Keytruda therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Keytruda market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Segment by Type
100mg/Vail
50mg/Vail
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Keytruda market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Keytruda, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Keytruda industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Keytruda in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Keytruda introduction, etc. Keytruda Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Keytruda market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices